Skip to main content
. Author manuscript; available in PMC: 2013 Aug 28.
Published in final edited form as: BioDrugs. 2012 Aug 1;26(4):235–244. doi: 10.2165/11631600-000000000-00000

Fig. 3.

Fig. 3

Diagrammatic representation of some potential future therapeutics. Targeting ligands/peptides against brain tumor-associated receptors will be fused to a nuclear localization signal, pro-apoptotic (KLAKLAK)2 peptides, or various radioisotopes and labels. D2=translocation/processing domain of Pseudomonas aeruginosa exotoxin A; NLS=nuclear localization signal.